Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.

Source:http://linkedlifedata.com/resource/pubmed/id/6537999

Download in:

View as

General Info

PMID
6537999